Swab the spot, pinch up a fold of skin, and insert the needle at a 45-degree angle, then inject slowly. The usual sites are the lower belly at least 2 inches from the navel, the outer thigh and the back of the upper arm.
Seven steps, and it is easier than it looks
Most people are comfortable with subcutaneous injection after the first one or two. The needles involved are very thin and cause minimal discomfort.
1. Use an insulin syringe. A U-100 barrel, 0.5 mL or 1 mL, with the fine short needle these come fitted with. They are made for exactly this injection.
2. Draw your dose from the reconstituted vial, after swabbing the stopper.
3. Choose an injection site. Lower abdomen at least 2 inches from the navel, outer thigh, or the back of the upper arm.
4. Clean the site with an alcohol swab and let it dry. Injecting through wet alcohol stings and defeats the purpose.
5. Pinch the skin to create a fold of subcutaneous tissue. This lifts the fat layer away from muscle.
6. Insert the needle at a 45-degree angle and inject slowly.
7. Withdraw and apply light pressure if needed.
Why 45 degrees
Subcutaneous means into the fat layer just beneath the skin, not into muscle, and not intradermally.
A 45-degree angle into pinched tissue reliably lands in that layer across a range of body compositions. Ninety degrees works with a short needle and adequate subcutaneous fat, but the pinch-and-45 approach is the more forgiving default and it is what our material specifies.
Injecting slowly matters too. Fast injection into a small tissue space causes more discomfort and more site irritation.
Why gauge matters
Higher gauge numbers mean thinner needles, and the U-100 insulin syringes this material assumes already sit at the thin end of that scale.
Thinner needles hurt less and cause less tissue trauma, which is why the FITTER Forward expert recommendations on insulin injection favour the finest needle you can work with, and say the same choices carry over to non-insulin injectables. There is no benefit to a wider needle for subcutaneous peptide injection: the volumes are small and the solution is thin. Buy an insulin syringe intended for subcutaneous injection and that choice is already made for you.
Use a new syringe for every injection. Reused needles are dull, which causes more pain and more tissue damage, and they are no longer sterile. If the needle touches any non-sterile surface at any point before injection, discard it.
Local versus systemic, again
Where you inject depends on the compound.
BPC-157 should go as close to the injury as practical, because the angiogenic effect is local.
TB-500 protocols allow any site. They treat it as acting through the whole body, a view taken from its parent protein that has not been tested for TB-500 in people.
Tesamorelin goes into the abdomen with rotating sites, avoiding the navel area.
Retatrutide rotates between abdomen, thigh and upper arm.
If a protocol specifies a site and you do not know why, the answer is nearly always this distinction.
What normal looks like afterwards
Mild redness or soreness at the site is common across most of these compounds and generally resolves within hours. Rotating sites and swabbing beforehand both reduce it.
What is not normal: redness that spreads beyond the immediate area, or persists. That is the point at which our tesamorelin protocol says to stop and consult a provider. Persistent injection site bumps are also named in the MOTS-C protocol as a reason to stop.
The distinction is between a local reaction that fades and one that expands. The first is expected. The second is a signal.